Drugs / NE-58095 DR
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02063854 | Feb 2014 → Nov 2015 | osteoporosis | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NE-58095 DR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02063854 ↗ |
| Route | Oral | “NE-58095 DR 25 mg tablet, orally, once, monthly” NCT02063854 ↗ |